Correction of diet-induced hyperglycemia, hyperinsulinemia, and skeletal muscle insulin resistance by moderate hyperleptinemia.
about
Overconsumption of dietary fat and alcohol: mechanisms involving lipids and hypothalamic peptidesLeptin's role in lipodystrophic and nonlipodystrophic insulin-resistant and diabetic individualsActivation of direct and indirect pathways of glycogen synthesis by hepatic overexpression of protein targeting to glycogenStimulation of nicotine reward and central cholinergic activity in Sprague-Dawley rats exposed perinatally to a fat-rich diet.Estimation of insulin secretion, glucose uptake by tissues, and liver handling of glucose using a mathematical model of glucose-insulin homeostasis in lean and obese mice.Expression of fatty acid synthase in nonalcoholic fatty liver disease.Leptin in human physiology and pathophysiology.Effect of dietary fatty acid composition on food intake, triglycerides, and hypothalamic peptidesAmelioration of obesity, glucose intolerance, and oxidative stress in high-fat diet and low-dose streptozotocin-induced diabetic rats by combination consisting of "curcumin with piperine and quercetin"Involvement of cholinergic mechanisms in the behavioral effects of dietary fat consumption.Negative regulation of human growth hormone gene expression by insulin is dependent on hypoxia-inducible factor binding in primary non-tumor pituitary cells.The role of leptin in the control of insulin-glucose axis.Effect of chronic psychosocial stress on nonalcoholic steatohepatitis in miceLeptin augments the acute suppressive effects of insulin on hepatic very low-density lipoprotein production in rats.High-fat feeding increases insulin receptor and IRS-1 coimmunoprecipitation with SOCS-3, IKKalpha/beta phosphorylation and decreases PI-3 kinase activity in muscle.Regulation of insulin synthesis and secretion and pancreatic Beta-cell dysfunction in diabetes.Hepatocyte growth factor is a novel stimulator of glucose uptake and metabolism in skeletal muscle cells.In vivo regulation of SREBP-1c in skeletal muscle: effects of nutritional status, glucose, insulin, and leptin.Autophagy reduces acute ethanol-induced hepatotoxicity and steatosis in mice.Hypertriglyceridemia in female rats during pregnancy induces obesity in male offspring via altering hypothalamic leptin signaling.High fat diet and body weight have different effects on cannabinoid CB(1) receptor expression in rat nodose ganglia.Restoring AS160 phosphorylation rescues skeletal muscle insulin resistance and fatty acid oxidation while not reducing intramuscular lipids.Fatty acid oxidation and triacylglycerol hydrolysis are enhanced after chronic leptin treatment in rats.Preserved direct hepatic insulin action in rats with diet-induced hepatic steatosis.Hepatic insulin gene therapy prevents deterioration of vascular function and improves adipocytokine profile in STZ-diabetic rats.Insulin-stimulated plasma membrane association and activation of Akt2, aPKC zeta and aPKC lambda in high fat fed rodent skeletal muscle.Metoprolol improves cardiac function and modulates cardiac metabolism in the streptozotocin-diabetic rat.Diet-induced obesity and acute hyperlipidemia reduce IkappaBalpha levels in rat skeletal muscle in a fiber-type dependent manner.
P2860
Q24678376-5ED19615-44EE-4D28-8125-1606FC34076DQ26859118-29126C3F-DAE4-4DC9-80A3-2B3C1321BED4Q28511989-ABF97CBD-A81D-4643-B61D-A5BC207872A1Q33552906-0667B146-3223-4D2A-945B-906C63414F85Q33774989-1C861A68-7703-461B-98AA-AFABDBC4BF9FQ33962008-79E6042D-CB9E-43C7-9B10-92BEC965C355Q35321788-28250B8C-A32C-40A7-9ECB-D55A312FC8AAQ35613295-CCC776C9-B3FB-47C7-8F53-631CA58A9CA1Q35864415-AB65A86B-49CD-47FE-9BC1-2B83911971A9Q36163922-D4F69BBC-E44B-4747-90D7-7836DA966448Q36286099-AF29C151-554C-4572-9193-010FB26EBF63Q36746954-022257FA-3DBC-4681-BEE0-38E4D4C54758Q37054565-7BB0D69B-A1D7-401B-B163-C47F56DC8CF5Q37166048-62DBB9AC-BD0E-4CE8-9DF0-9DA0304973C3Q37217965-139367FE-E0AD-4521-B656-C6845A2CA3FBQ37603286-0F2A6EEF-A697-42EB-AE39-CF65D4DF50ADQ38291347-B5EFBE67-2E00-4ECD-BF5A-0A7D8F627BF4Q38344056-637820C2-1456-4C63-84F0-B28AC1DFD21CQ39675853-EDBE0325-0B71-4724-AC77-85CA56FE2CF2Q41593214-60BCF31C-03B8-4557-9615-0B9BF3AC6C49Q42091620-FB243498-D239-4FF5-AAF5-08643BC804A7Q42459278-3FA9A2D2-EEBC-4EBA-9370-A0A79A7D5055Q43879192-95785345-C37B-4FED-A259-8F860C6DA0BBQ44726974-FDC10503-643C-4638-8DBC-97F1106E30B2Q45886182-A289C4B3-A9AA-4A1E-9AD5-D762CCF9E3E5Q46414639-62765324-6C6B-4C21-8369-8AAC827FF638Q46802160-105E51D9-6827-45CD-B482-E2DEF05CABF5Q53848632-7F637446-F4DF-4079-BACF-074655AEE434
P2860
Correction of diet-induced hyperglycemia, hyperinsulinemia, and skeletal muscle insulin resistance by moderate hyperleptinemia.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh
2000年學術文章
@zh-hant
name
Correction of diet-induced hyp ...... e by moderate hyperleptinemia.
@en
Correction of diet-induced hyp ...... e by moderate hyperleptinemia.
@nl
type
label
Correction of diet-induced hyp ...... e by moderate hyperleptinemia.
@en
Correction of diet-induced hyp ...... e by moderate hyperleptinemia.
@nl
prefLabel
Correction of diet-induced hyp ...... e by moderate hyperleptinemia.
@en
Correction of diet-induced hyp ...... e by moderate hyperleptinemia.
@nl
P2093
P1476
Correction of diet-induced hyp ...... e by moderate hyperleptinemia.
@en
P2093
C B Newgard
C J Rhodes
R Buettner
R M O'Doherty
P304
P356
10.1152/AJPENDO.2000.278.3.E563
P577
2000-03-01T00:00:00Z